Objective: We evaluated the development of ICU survival of patients with hematopoietic malignancies and discussed changes in admittance policies.
Method: We compared 166 patients treated between 2009 and 2012 with 138 patients treated between 2013 and 2016. Patient characteristics and outcome were analyzed.